Day: August 30, 2023

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

Written by Customer Service on August 30, 2023. Posted in Earnings Releases And Operating Results.

Company focused on accelerating clinical programs for PORT-2, PORT-6, and PORT-7 WESTPORT, Conn., Aug. 30, 2023 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported financial results for the fiscal quarter ended June 30, 2023. “In recent weeks we have continued to build on the favorable interim data and early evidence of single agent activity from the Phase 1/2 trial of our lead program, PORT-2, presented at the 2023 annual meeting of the American Society for Clinical Oncology (ASCO) in June, and our near-term focus is defining the recommended Phase 2 dose,” said Dr. Ian Walters, Chief Executive Officer, and Chairman of Portage Biotech. “We have transferred sponsorship of the clinical trial...

Golden Grail Beverages Elevates Digital Experience with Website Relaunch

Written by Customer Service on August 30, 2023. Posted in Public Companies.

FORT LAUDERDALE, Fla., Aug. 30, 2023 (GLOBE NEWSWIRE) — Golden Grail Technology, doing business as Golden Grail Beverages (OTC: GOGY) is proud to announce the official launch of its newly redesigned website, www.goldengrailbeverages.com. The site boasts visually appealing portfolio pages, engaging blogs, a dedicated investor hub, and an upcoming e-commerce section. The website’s modern design offers a fresh and intuitive user experience tailored for today’s consumers with detailed descriptions and captivating images. The streamlined navigation system ensures easy access to information, while the mobile-responsive design guarantees seamless browsing across all devices. One of the standout features is the visually appealing portfolio pages, which showcase Golden Grail Beverages’ diverse range of products. Golden...

Clene to Present at Upcoming September Conferences

Written by Customer Service on August 30, 2023. Posted in Public Companies.

SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis, today announced that it will participate in the following investor conferences in September. H.C. Wainwright 25th Annual Global Investment ConferenceDate: September 11-13, 2023Location: Lotte New York Palace Hotel, New York, NYDate and Time of Presentation: Available September 11, 2023, at 7:00 a.m. ETFormat: Corporate Presentation and 1×1 meetingsWebcast Link: https://journey.ct.events/view/3eb50cf4-1561-4363-8e78-ac2c56092fb6 Cantor...

Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients

Written by Customer Service on August 30, 2023. Posted in Public Companies.

Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad’s lifelong work NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Aug. 30, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a medical diagnostics and related solutions company, today announced that the United States Patent & Trademark Office (USPTO) has issued a Notice of Allowance for NLC Pharma’s patent application entitled “Compounds for Treating a Coronavirus Infection” prosecuted from the groundbreaking work of Dr. Dorit Arad. The Notice of Allowance covers the use of key compounds contained in the ingredients in Tollovid™ and Tollovir™ (NLC-V-01, NLC-001 or 3CL-001). The allowed claims are directed, among other things, to the administration of compounds to a subject...

Perspective Therapeutics to Present at the World Molecular Imaging Congress 2023

Written by Customer Service on August 30, 2023. Posted in Public Companies.

RICHLAND, WASH. & CORALVILLE, IOWA, Aug. 30, 2023 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced that it will have two presentations at the upcoming World Molecular Imaging Congress (WMIC) 2023, hosted by the World Molecular Imaging Society (WMIS). The conference is being held in Prague, Czech Republic, from September 5-9, 2023. “We are pleased with our team’s progress in pioneering the development of promising image-guided, lead-based, alpha particle therapies.” said Thijs Spoor, Chief Executive Officer at Perspective Therapeutics. “Our team continues to deepen our pipeline with exceptional data from our novel radioligand, [203/212Pb]PSC-PEG3-Adma, for image-guided pre-targeted alpha particle therapy; and our preclinical data for our lead-based alpha...

MasterCraft Boat Holdings, Inc. Reports Fiscal 2023 Results

Written by Customer Service on August 30, 2023. Posted in Earnings Releases And Operating Results.

VONORE, Tenn., Aug. 30, 2023 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2023 fourth quarter and year ended June 30, 2023. Unless otherwise indicated, the highlights and commentary provided herein relate to our continuing operations, which exclude the NauticStar segment results reported as discontinued operations. Fourth Quarter Highlights:Net sales for the fourth quarter were $166.6 million, down 15.5% from the prior-year period Net income from continuing operations was $23.1 million, or $1.32 per diluted share, down 31.2% and 28.6%, respectively, from the prior-year period Diluted Adjusted Net Income per share, a non-GAAP measure, was $1.37, down 28.6% from the prior-year period Adjusted EBITDA, a non-GAAP measure, was $32.7 million, down 31.3% from the...

Water Ways Reports Q2 2023 Financial Results

Written by Customer Service on August 30, 2023. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 30, 2023 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) (“Water Ways” or the “Company“), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces the filing of its Interim Financial Statements (the “Statements“) and Managements Discussion and Analysis (the “MD&A“) for the three and six months period ended June 30, 2023. A comprehensive discussion of Water Ways’ financial position and results of operations is provided in the MD&A, filed on SEDAR (www.sedar.com). Mr. Ohad Haber, CEO and Chairman of the Board of Water Ways states: “The second quarter of 2023 continued the...

FANHUA Reports Second Quarter 2023 Unaudited Financial Results

Written by Customer Service on August 30, 2023. Posted in Earnings Releases And Operating Results.

Operating Income for the Second Quarter of 2023 Up 177.3% YoY, Beating Prior Guidance GUANGZHOU, China, Aug. 30, 2023 (GLOBE NEWSWIRE) — FANHUA Inc. (Nasdaq: FANH) (the “Company” or “FANHUA”), a leading independent financial services provider in China, today announced its unaudited financial results for the second quarter ended June 30, 20231. Financial Highlights for the Second Quarter of 2023:(In thousands, except per ADS data and percentages) 2022Q2(RMB) 2023Q2(RMB) 2023Q2(US$) Change %Total net revenues 703,116 1,132,640 156,198 61.1Operating income 31,028 86,032 11,864 177.3Net income attributable to shareholders 32,123 76,515 10,551 138.2Adjusted EBITDA2 35,711 104,141 14,361 191.6Diluted net income per ADS 0.60 1.42 0.20 136.7Diluted adjusted EBITDA per ADS3 0.66 1.93 0.27 192.4Cash, cash equivalent,...

Entourage Health Reports Second Quarter 2023 Financial Results

Written by Customer Service on August 30, 2023. Posted in Earnings Releases And Operating Results.

The Company achieved a total revenue of $13.3 million, driven by an 8% increase in adult-use revenue and a significant 45% increase in pre-roll revenue year-over-year Gross Profit Before Fair Value Changes has surged to $2.15 million, indicating a substantial margin of 21% and a considerable year-over-year increase of 354% Adjusted EBITDA showed a 28% improvement as the Company realizes benefits from strategic transformation initiatives Strathroy sale enables BMO loan repayment, bolstering the Company’s financial agility Management will host a conference call on August 30, 2023, at 10 a.m. Eastern TimeTORONTO, Aug. 30, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis...

Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 8, 2023

Written by Customer Service on August 30, 2023. Posted in Mergers And Acquisitions.

THE WOODLANDS, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) — Graf Acquisition Corp. IV (NYSE: GFOR, GFOR-UN, GFOR-WT) (the “Company” or “Graf”), announced today that it intends to adjourn, without conducting any business, the special meeting of its stockholders to be held to approve, among other things, the previously announced business combination (the “Business Combination”) with NKGen Biotech, Inc. (“NKGen” and such special meeting, the “Special Meeting”), which is scheduled to occur at 10:00 a.m., Eastern time, on August 30, 2023, and to reconvene the Special Meeting at 10:30 a.m., Eastern time, on September 8, 2023. The Special Meeting will still be held virtually at https://www.cstproxy.com/grafiv/sm2023. The Company has received overwhelming support for the approval of the Business Combination and has received enough votes to...

Day: August 30, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals